IKK 16
目录号: PL06800 纯度: ≥98%
CAS No. :873225-46-8
商品编号 规格 价格 会员价 是否有货 数量
PL06800-5mg 5mg ¥1236.36 请登录
PL06800-10mg 10mg ¥2151.27 请登录
PL06800-50mg 50mg ¥6429.09 请登录
PL06800-100mg 100mg ¥9643.64 请登录
PL06800-200mg 200mg 询价 询价
PL06800-500mg 500mg 询价 询价
PL06800-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1360.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
IKK 16
中文别名
IKK-16 (IKK Inhibitor VII) 抑制剂;IKK-16,选择性IKK抑制剂
英文名称
IKK 16
英文别名
[4-[(4-Benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone;IKK-16;IKK-16 (IKK Inhibitor VII);[4-[[4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone;4-[(4-BENZO[B]THIEN-2-YL-2-PYRIMIDINYL)AMINO]PHENYL][4-(1-PYRROLIDINYL)-1-PIPERIDINYL]-METHANONE;IKK 16
Cas No.
873225-46-8
分子式
C28H29N5Os
分子量
483.63
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
IKK 16 是一种选择性的 IκB 激酶 (IKK) 抑制剂,作用于 IKK2,IKK complex 和 IKK1,IC50 分别为 40 nM,70 nM 和 200 nM。IKK 16 还抑制富亮氨酸重复激酶 2 (LRRK 2),IC50 为 50 nM。
生物活性
IKK 16 is a selective IκB kinase (IKK) inhibitor for IKK2, IKK complex and IKK1 with IC 50 s of 40 nM, 70 nM and 200 nM, respectively. IKK16 also inhibits leucine-rich repeat kinase-2 (LRRK2) with an IC 50 of 50 nM.
性状
Solid
IC50 & Target[1][2]
IKK1 200 nM (IC50) IKK2 40 nM (IC50
体外研究(In Vitro)
IKK 16 is a potent inhibitor of IKK2 with IC50 value of 40 nM. IKK 16, a leucine-rich repeat kinase-2 (LRRK2) kinase inhibitor, exhibits in vitro IC50s of 50 nM. IKK 16 exhibits sub-micromolar IC50 concentrations for LRRK2 in vitro, which is lower than what observed for cellular inhibition of Ser935 phosphorylation. IKK 16 (20 μM) can inhibit LRRK2 Ser935 phosphorylation in HEK293 GFP-LRRK2G2019S cells (GS) or A2016T/G2019S (IRM) cells in vitro. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
IKK 16 also demonstrates significant in vivo activity in an acute model of cytokine release. Both routes of administration of IKK 16 (30 mg/kg, sc) or orally (30 mg/kg, p.o) at the indicated dose results in a significant inhibition of 86% (sc) and 75% (p.o.). IKK 16(10 mg/kg, sc) is also active in the thioglycollate-induced peritonitis model in the mouse. The maximal inhibition of neutrophil extravasation in this model is about 50%. Treatment of septic mice with IKK 16 (1 mg/kg body weight i.v.) results in a significantly increased degree of phosphorylation (P<0.05) of serine residues on Akt and eNOS in the liver. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Waelchli R, et al. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg Med Chem Lett. Bioorg Med Chem Lett. 2006 Jan 1;16(1):108-12.
[2]. Hermanson SB, et al. Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation. PLoS One. 2012;7(8):e43580.
溶解度数据
In Vitro: DMSO : ≥ 27 mg/mL (55.83 mM)H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2